BioCatalystWatch
BHVNWorkspace / BHVN / OverviewCompany library
Price
Market cap
Next catalystExpected 2026BHV-1400 — planned pivotal IgAN study · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Small molecule

IgG1 × IgG2 × IgG4 × TSHR-IgG1 autoantibody

BHV-1530

FGFR3

PreINDP1P2P3FilingApproved

BHV-1530

FGFR3

PreINDP1P2P3FilingApproved
BHV-1400

Gd-IgA1 × Gd-IgA1 complexes

PreINDP1P2FilingApproved
Upcoming / outlook

BHV-1510

Trop-2

PreINDP1P2P3FilingApproved
Upcoming / outlook

BHV-1600

Small molecule

β1AR autoantibodies

PreINDP1P2P3FilingApproved
Upcoming / outlook

BHV-1450

IgG4 × Anti-Dsg3 IgG4

PreINDP1P2P3FilingApproved
Upcoming / outlook

BHV-1500

CD30

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

BHV-1600

Small molecule

β1AR autoantibodies

PreINDP1P2P3FilingApproved
Upcoming / outlook

BHV-1500

CD30

PreINDP1P2P3FilingApproved
Upcoming / outlook

BHV-1400

Gd-IgA1 × Gd-IgA1 complexes

PreINDP1P2FilingApproved
Upcoming / outlook

BHV-1450

IgG4 × Anti-Dsg3 IgG4

PreINDP1P2P3FilingApproved
Upcoming / outlook

BHV-1510

Trop-2

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

BHV-1310

IgG

Small molecule

IgG1 × IgG2 × IgG4 × TSHR-IgG1 autoantibody

BHV-1420

PLA2R autoantibody

PreINDP1P2P3FilingApproved
BHV-1510

Trop-2

PreINDP1P2P3FilingApproved
BHV-1510

Trop-2

BHV-1510

Trop-2

Small molecule

IgG1 × IgG2 × IgG4 × TSHR-IgG1 autoantibody

PreINDP1P2P3FilingApproved
BHV-1400

Gd-IgA1 × Gd-IgA1 complexes

PreINDP1P2P3FilingApproved

Partner / License out

BHV-7000

Kv7.2/Kv7.3

History / paused

BHV-4157

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BHVN PR & News

PR & News

BHVN SEC archive